Shirley Hodgson

Q: What Schools Are Affiliated With Shirley Hodgson

Shirley Hodgson is affiliated with the following schools: St George's, University of London, University of Cambridge

Shirley Hodgson's AcademicInfluence.com Rankings

Shirley Hodgson

Biology

#3033

World Rank

#4697

Historical Rank

Genetics

#380

World Rank

#443

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Shirley Hodgson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Shirley Victoria Penrose Hodgson, FRCP, FRSB is a British geneticist. Biography Hodgson studied at Somerville College, Oxford. She worked as a GP, then performed as a locum in clinical genetics at Guy's Hospital, saying she found the subject "irresistible". She became Senior Registrar in Clinical Genetics for the South Thames Regional Genetics Centre and Honorary Senior Registrar at Hammersmith Hospital, London, from 1983 to 1988; then Consultant Geneticist at Addenbrooke's Hospital from 1988 to 1990. In the 1990s, she led the regional cancer genetics service at Guy's and St Thomas' Hospital.

(See a Problem?)

Shirley Hodgson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers (2017) (1644)
Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. (2003) (897)
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. (2005) (845)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial (2011) (826)
Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. (2013) (802)
Peutz–Jeghers syndrome: a systematic review and recommendations for management (2010) (662)
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. (1998) (661)
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts (2013) (656)
Localization of the gene for Cowden disease to chromosome 10q22–23 (1996) (641)
Guidelines for the clinical management of familial adenomatous polyposis (FAP) (2008) (635)
Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. (2013) (619)
The human PAX6 gene is mutated in two patients with aniridia (1992) (572)
PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. (1999) (570)
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors (2003) (558)
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) (2007) (539)
Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome) (2011) (452)
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk (2013) (405)
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. (2015) (390)
Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD (2010) (333)
Whole-genome sequencing in health care (2013) (295)
DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer (2013) (275)
Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. (2007) (261)
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study (2018) (256)
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. (2001) (255)
Polyclonal Origin of Colonic Adenomas in an XO/XY Patient with FAP (1996) (245)
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. (2003) (241)
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study (2014) (222)
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. (1998) (220)
The SPCH1 region on human 7q31: genomic characterization of the critical interval and localization of translocations associated with speech and language disorder. (2000) (212)
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers (2017) (211)
Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. (2013) (210)
Abnormal expression of wild type p53 protein in normal cells of a cancer family patient (1992) (204)
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. (2010) (196)
PAX6 mutations in aniridia. (1993) (176)
Further observations on LKB1/STK11 status and cancer risk in Peutz–Jeghers syndrome (2003) (174)
Germline PTEN mutations in Cowden syndrome-like families. (1998) (157)
Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. (1998) (151)
Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple” colorectal adenomas (2002) (150)
Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC) (2007) (145)
Phenotypic expression in familial adenomatous polyposis: partial prediction by mutation analysis. (1994) (144)
Tumour risks and genotype–phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD (2018) (143)
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores (2017) (142)
Genome-wide association study identifies a common variant associated with risk of endometrial cancer (2011) (142)
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial (2020) (141)
Clinical and molecular features of the hereditary mixed polyposis syndrome. (1997) (141)
Genetic predisposition to cancer. (2005) (140)
Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. (2006) (138)
Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation. (1996) (135)
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. (2012) (129)
Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers. (2003) (129)
Analysis of genetic and phenotypic heterogeneity in juvenile polyposis (2000) (128)
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. (2009) (124)
Mutation cluster region, association between germline and somatic mutations and genotype-phenotype correlation in upper gastrointestinal familial adenomatous polyposis. (2002) (124)
Refining the relation between ‘first hits’ and ‘second hits’ at the APC locus: the ‘loose fit’ model and evidence for differences in somatic mutation spectra among patients (2003) (123)
Identification of nine new susceptibility loci for endometrial cancer (2018) (122)
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe (2010) (121)
Expression of HIF-1α, HIF-2α (EPAS1), and Their Target Genes in Paraganglioma and Pheochromocytoma with VHL and SDH Mutations (2006) (120)
Solitary juvenile polyps: not a marker for subsequent malignancy. (1993) (118)
Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome (2014) (116)
Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. (1999) (116)
Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England (2001) (115)
Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinics. European Familial Breast Cancer Collaborative Group. (1998) (113)
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (112)
The risk of subsequent primary cancers after colorectal cancer in southeast England (2002) (112)
Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus on 10q22‐23, in hamartomas from patients with cowden syndrome and germline PTEN mutation (1998) (112)
Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium. (2000) (111)
Hypothyroidism after treatment for nonthyroid head and neck cancer. (2000) (111)
Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. (2004) (111)
Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? (1994) (110)
Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women (2002) (109)
An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. (2003) (109)
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study (2011) (104)
Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. (1998) (104)
A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. (2005) (104)
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC (2002) (103)
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility (2003) (103)
Identification of germline missense mutations and rare allelic variants in the ATM gene in early‐onset breast cancer (1999) (100)
A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma. (2013) (99)
TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres (2011) (99)
Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome. (1997) (97)
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers (2012) (92)
Deletions in the 5' region of dystrophin and resulting phenotypes. (1994) (92)
Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study. (2015) (91)
The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine (2010) (89)
Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses (2000) (89)
Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia (2004) (87)
Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes (2002) (87)
A survey of phenotypic features in juvenile polyposis. (1998) (84)
Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. (1989) (84)
Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families (1997) (84)
Support for linkage of autism and specific language impairment to 7q3 from two chromosome rearrangements involving band 7q31. (2000) (83)
Fanconi anaemia (2003) (82)
Large genomic deletions in AIP in pituitary adenoma predisposition. (2008) (82)
Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6q. (1996) (81)
Whole-genome methylation analysis of benign and malignant colorectal tumours (2013) (80)
Evidence of linkage of the inflammatory bowel disease susceptibility locus on chromosome 16 (IBD1) to ulcerative colitis. (1998) (80)
Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations. (2006) (78)
Leiden open variation database of the MUTYH gene (2010) (77)
Bi‐allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia (2003) (74)
Emberger syndrome—Primary lymphedema with myelodysplasia: Report of seven new cases (2010) (74)
Screening SMAD1,SMAD2, SMAD3, andSMAD5 for germline mutations in juvenile polyposis syndrome (1999) (72)
Familial Non-VHL Clear Cell (Conventional) Renal Cell Carcinoma: Clinical Features, Segregation Analysis, and Mutation Analysis of FLCN (2008) (72)
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (2017) (70)
A distinctive, low‐grade oncocytic fumarate hydratase‐deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase‐deficient renal cell carcinoma (2017) (69)
RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B. (2006) (68)
A balanced de novo X/autosome translocation in a girl with manifestations of Lowe syndrome. (1986) (67)
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities (2011) (66)
Late Toxicity Is Not Increased in BRCA1/BRCA2 Mutation Carriers Undergoing Breast Radiotherapy in the United Kingdom (2006) (65)
Five endometrial cancer risk loci identified through genome-wide association analysis (2016) (64)
Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non‐syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma (2013) (64)
Variables associated with the risk of colorectal adenomas in asymptomatic patients with a family history of colorectal cancer. (1995) (64)
Exonic STK11 deletions are not a rare cause of Peutz-Jeghers syndrome (2005) (62)
Two cases of 5q deletions in patients with familial adenomatous polyposis: possible link with Caroli's disease. (1993) (62)
Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. (2003) (62)
Guidelines for Follow-Up of Women at High Risk for Inherited Breast Cancer: Consensus Statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer (2002) (61)
Sequence variants of the estrogen receptor (ER) gene found in breast cancer patients with ER negative and progesterone receptor positive tumors. (1996) (61)
Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome. (1996) (60)
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2012) (60)
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (58)
Use of SSCP analysis to identify germline mutations in HNPCC families fulfilling the Amsterdam criteria (1997) (58)
Familial psychiatric presentation of Huntington's disease. (1996) (58)
Familial breast cancer: an investigation into the outcome of treatment for early stage disease (2004) (57)
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. (2011) (55)
Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England. (2003) (55)
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer (2016) (54)
Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN (2012) (53)
Colorectal cancer in the young: trends, characteristics and outcome (2011) (53)
Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient (2010) (52)
p53 protein detected by immunohistochemical staining is not always mutant. (1993) (52)
Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability (1992) (52)
The prevalence of a family history of cancer in general practice. (1995) (51)
A probable case of the homozygous condition of the aniridia gene. (1980) (51)
High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia (2004) (50)
Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases (2004) (50)
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer (2015) (50)
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk (2014) (47)
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers (2012) (47)
Loss of heterozygosity of the oestrogen receptor gene in breast cancer. (1995) (46)
Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA) (2003) (45)
Italian appeal court: a genetic predisposition to commit murder? (2010) (43)
Family history and survival in premenopausal breast cancer. (1998) (43)
Mechanisms of inherited cancer susceptibility (2007) (42)
A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage. (1995) (41)
Germline BRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent with BRCA1:ψBRCA1 recombination (2002) (41)
No news is (not necessarily) good news: Impact of preliminary results for BRCA1 mutation searches (2002) (41)
SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients (1999) (41)
Is telomere length in peripheral blood lymphocytes correlated with cancer susceptibility or radiosensitivity? (2007) (40)
The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). (2002) (40)
Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease (2000) (40)
Genome-Wide Association Study Identifies a Possible Susceptibility Locus for Endometrial Cancer (2012) (39)
Apoptosis, ageing and cancer susceptibility (2003) (39)
A Viral Aetiology for Breast Cancer: Time to Re-Examine the Postulate (2004) (38)
Expression and DNA methylation of TNF, IFNG and FOXP3 in colorectal cancer and their prognostic significance (2014) (38)
Analysis of the contribution of HLA genes to genetic predisposition in inflammatory bowel disease. (1996) (37)
Cribriform variant papillary thyroid cancer: a characteristic of familial adenomatous polyposis. (2001) (37)
AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study (2007) (37)
Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma. (2003) (37)
Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility (2007) (37)
THE PRICE OF LIBERTY (1980) (37)
Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer (1999) (36)
Utilisation of Prophylactic Mastectomy in 10 European Centres (2002) (35)
Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer (1998) (35)
Cancer incidence in relatives of British Fanconi Anaemia patients (2008) (34)
Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk (2014) (34)
Is colorectal surveillance indicated in patients with PTEN mutations? (2012) (34)
What motivates interest in attending a familial cancer genetics clinic? (2004) (34)
Current Policies for Surveillance and Management in Women at Risk for Breast and Ovarian Cancer: A Survey among 16 European Family Cancer Clinics (2002) (33)
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1 (2015) (32)
Genetic Testing and Common Disorders: How to Assess Relevance and Possibilities (2011) (32)
Acute Chemotherapy–Related Toxicity Is Not Increased in BRCA1 and BRCA2 Mutation Carriers Treated for Breast Cancer in the United Kingdom (2006) (31)
Deletion of chromosome 3q proximal region gives rise to a variable phenotype (1998) (31)
APC mutation associated with late onset of familial adenomatous polyposis. (1994) (30)
Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome. (1995) (30)
A study of genomic instability in early preneoplastic colonic lesions (2012) (29)
Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (29)
Novel frameshift mutations in the RP2 gene and polymorphic variants (2000) (29)
Endocardial fibroelastosis: possible X linked inheritance. (1987) (28)
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) (2009) (28)
Frequency of germline hereditary non-polyposis colorectal cancer gene mutations in patients with multiple or early onset colorectal adenomas (1997) (27)
Ethical, Social and Economic Issues in Familial Breast Cancer: A Compilation of Views from the E.C. Biomed II Demonstration Project (2002) (27)
Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck. (2005) (26)
Three cases of 16q duplication. (1991) (26)
Attitudes to predictive DNA testing in familial adenomatous polyposis. (1996) (26)
Genomics and breast cancer: the different levels of inherited susceptibility (2009) (26)
Pallister–Killian syndrome presenting through nuchal translucency screening for trisomy 21 (2000) (25)
Patients' and professionals' opinions of services for people at an increased risk of colorectal cancer: an exploratory qualitative study (2004) (25)
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer (2020) (25)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer (2016) (25)
Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy. (1989) (25)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (25)
Suggested Screening Guidelines for Familial Colorectal Cancer (1995) (25)
Heritability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins (2006) (24)
Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families (2005) (24)
Two cases of X/autosome translocation in females with incontinentia pigmenti (2004) (24)
Is chromosome radiosensitivity and apoptotic response to irradiation correlated with cancer susceptibility? (2007) (24)
Breast cancer genetics: Unsolved questions and open perspectives in an expanding clinical practice (2004) (24)
Anticipated reactions to genetic testing for hereditary non‐polyposis colorectal cancer susceptibility * (2004) (23)
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. (2015) (23)
The radiology of Coffin-Lowry syndrome. (1990) (22)
The application of linkage analysis to genetic counselling in families with Duchenne or Becker muscular dystrophy. (1987) (22)
Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis. (1994) (22)
PRENATAL TESTING FOR DUCHENNE AND BECKER MUSCULAR DYSTROPHY (1988) (22)
Phenotypic variation in hereditary nonpolyposis colon cancer syndrome association with infiltrative fibromatosis (desmoid tumor) (1992) (21)
Cancer risks in women with 2 breast or ovarian cancers: Clues to genetic cancer susceptibility (2001) (21)
Exploring the link between MORF4L1 and risk of breast cancer (2011) (21)
Germline mutations in the TGF-β and Wnt signalling pathways are a rare cause of the “multiple” adenoma phenotype (2003) (21)
Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin (2007) (21)
GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer. (2016) (21)
The screening of Duchenne muscular dystrophy patients for submicroscopic deletions. (1986) (20)
Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3). (2014) (20)
Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases (2003) (20)
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers (2011) (19)
Familial adenomatous polyposis presentig with childhood desmoids (1997) (19)
Characterisation of human papillomavirus (HPV) genotypes in the Azorean population, Terceira island (2008) (18)
The Genomics of Colorectal Cancer: State of the Art (2008) (18)
Prenatal diagnosis of X-linked choroideremia with mental retardation, associated with a cytologically detectable X-chromosome deletion (1987) (18)
Carney triad versus Carney Stratakis syndrome: two cases which illustrate the difficulty in distinguishing between these conditions in individual patients (2010) (18)
A Practical Guide to Human Cancer Genetics (2013) (18)
Low prevalence of germlineBRCA1 mutations in early onset breast cancer without a family history (2000) (18)
Nine novel L1 CAM mutations in families with X‐linked hydrocephalus (1997) (18)
Sequence changes in predicted promoter elements of STK11/LKB1 are unlikely to contribute to Peutz-Jeghers syndrome (2005) (17)
A survey of the current clinical facilities for the management of familial cancer in Europe (2000) (17)
Linkage studies in Duchenne and Becker muscular dystrophies. (1986) (17)
19. MALE BREAST CANCER: AETIOLOGY, GENETICS AND CLINICAL MANAGEMENT (2002) (17)
UBE2QL1 is Disrupted by a Constitutional Translocation Associated with Renal Tumor Predisposition and is a Novel Candidate Renal Tumor Suppressor Gene (2013) (17)
Loss of Expression and Promoter Methylation of SLIT2 Are Associated with Sessile Serrated Adenoma Formation (2013) (16)
Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients (2020) (16)
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers (2012) (16)
Guidelines for the clinical management of Lynch (2007) (16)
Two brothers with an unbalanced 8;17 translocation and infantile pyloric stenosis (1995) (16)
Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics (2007) (16)
Juvenile polyposis (1995) (15)
DNA deletions in mild and severe Becker muscular dystrophy (1987) (15)
Cancer Genetics Services in Europe (2002) (15)
A mitotically stable marker chromosome negative for whole chromosome libraries, centromere probes and chromosome specific telomere regions: a novel class of supernumerary marker chromosome? (2001) (15)
The management of families affected by hereditary non-polyposis colorectal cancer (HNPCC) (2006) (15)
Insurance Implications for Individuals with a High Risk of Breast and Ovarian Cancer in Europe (2002) (14)
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 (2012) (14)
Rapid and efficient ATM mutation detection by fluorescent chemical cleavage of mismatch: identification of four novel mutations (1999) (14)
Regional proliferative patterns in the colon of patients at risk for hereditary nonpolyposis colorectal cancer (1997) (14)
Dominant transmission of Sprengel's shoulder and cleft palate (1981) (14)
Lymphocyte Telomere Length Is Long in BRCA1 and BRCA2 Mutation Carriers Regardless of Cancer-Affected Status (2014) (14)
Diagnosis and Management of Hereditary Thyroid Cancer. (2016) (14)
Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions (1999) (14)
Clinicoradiological manifestations of paraganglioma syndromes associated with succinyl dehydrogenase enzyme mutation (2011) (13)
No evidence that GATA3 rs570613 SNP modifies breast cancer risk (2009) (13)
No evidence of RET germline mutations in familial pituitary adenoma. (2011) (12)
The Johanson-Blizzard syndrome (1982) (12)
Molecular deletions in the Duchenne/Becker muscular dystrophy gene (1989) (12)
'Over-the-counter' genetic testing: what does it really mean for primary care? (2009) (12)
A novel activating mutation in the RET tyrosine kinase domain mediates neoplastic transformation. (2006) (12)
Fine-mapping of the HNF 1 B multicancer locus identi fi es candidate variants thatmediate endometrial cancer risk (2015) (11)
Apparent Mendelian inheritance of breast and colorectal cancer: chance, genetic heterogeneity or a new gene? (2004) (11)
Hyperkalaemic cardiac arrest in a manifesting carrier of Duchenne muscular dystrophy following general anaesthesia (2001) (10)
The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant (2021) (10)
Deletions of the entire APC gene are associated with sessile colonic adenomas. (1994) (10)
Inherited susceptibility to cancer : clinical, predictive, and ethical perspectives (1998) (10)
AURKA F 31 I Polymorphism and Breast Cancer Risk in BRCA 1 and BRCA 2 Mutation Carriers : A Consortium of Investigators of Modifiers of BRCA 1 / 2 Study (2007) (10)
An audit of screening for familial breast cancer before 50 years in the South Thames Region – have we got it right? (2004) (10)
FALSE POSITIVE IN PRENATAL DIAGNOSIS OF CYSTIC FIBROSIS (1988) (9)
Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array (2016) (9)
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2016) (9)
Screening results in a family cancer clinic: five years experience. (1993) (9)
A de novo X;13 translocation with abnormal phenotype. (1986) (8)
Polymorphic sequence variants in medicine: a challenge and an opportunity. (2003) (8)
Study comparing two types of screening provision for people with von Hippel-Lindau disease (2006) (8)
Exploring the link between MORF4L1 and risk of breast cancer (2011) (8)
Risk Estimation as a Decision-Making Tool for Genetic Analysis of the Breast Cancer Susceptibility Genes (2002) (8)
The impact of patenting on DNA diagnostic practice. (2008) (8)
A linkage study of Emery-Dreifuss muscular dystrophy (1986) (8)
Familial adenomatous polyposis presenting with childhood desmoids. (1997) (8)
Exonic STK 11 deletions are not a rare cause of Peutz-Jeghers syndrome (2006) (8)
DNA DELETION IN BOY WITH BECKER MUSCULAR DYSTROPHY (1986) (7)
Nance-Horan syndrome: a contiguous gene syndrome involving deletion of the amelogenin gene? A case report and molecular analysis. (2008) (7)
Cancer genetics and reproduction. (2010) (7)
A case of co-existing paraganglioma and thymoma (2015) (7)
Linkage of emery-dreifuss muscular dystrophy to the red/green cone pigment (RGCP) genes, proximal to factor VIII (1992) (7)
Insurance considerations for individuals with a high risk of breast cancer in Europe: Some recommendations (2000) (7)
Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility? (2004) (7)
Working with refugee families, trauma and exile in family relationships (2020) (7)
Moving health sovereignty in Africa – disease, governance, climate change (2015) (6)
Improving aid effectiveness in global health (2015) (6)
Nurse-led cancer genetics clinics in primary and secondary care in varied ethnic population areas: interaction with primary care to improve ascertainment of individuals from ethnic minorities (2007) (6)
Low Prevalence of BRCA1 Exon Rearrangements in Familial and Young Sporadic Breast Cancer Patients (2006) (6)
Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study. (2011) (6)
EMQN Best Practice Guidelines for Molecular Genetic Analysis in Hereditary Breast/Ovarian Cancer (2008) (5)
A short history of medical genetics (2009) (5)
Multiple colorectal adenomas, familial adenomatous polyposis and germline mutations in MYH (2003) (5)
Best Practice Guidelines for Molecular Genetic Analysis in Hereditary Breast / Ovarian Cancer (2008) (5)
Understanding West Africa’s Ebola epidemic (2017) (5)
A Novel Medical Treatment of Cushing's Due to Ectopic ACTH in a Patient With Neurofibromatosis Type 1 (2012) (5)
Familial Breast and Ovarian Cancer: Guidelines for the development of cancer genetics services (2002) (5)
Evidence against a major genetic basis for combined breast and colorectal cancer susceptibility (2006) (5)
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH 2 B 3 and TSHZ 1 (2015) (4)
Familial breast cancer: some social, economic and ethical issues (2000) (4)
Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk (2014) (4)
UBE 2 QL 1 is disrupted by a constitutional translocation associated with renal tumor predisposition and is a novel candidate renal tumor suppressor gene (4)
Cancer Genetics Services in the UK (1999) (4)
Blood and Lymph (2014) (4)
Cancer risk and genotype–phenotype correlations in PTEN hamartoma tumor syndrome (2013) (3)
Screening for familial ovarian cancer (2002) (3)
Mutation analysis of the Fanconi Anemia group A, C, E, F and G genes in sporadic acute myeloid leukemia. (2000) (3)
Loss of Mismatch Repair Protein Expression in Breast Carcinoma in Patients with Lynch Syndrome: Report of Two Cases (2013) (3)
Erratum: Patenting and licensing in genetic testing: Recommendations of the European Society of Human Genetics (European Journal of Human Genetics) (2008) vol. 16 (405-411) 10.1038/sj.ejhg.5201929) (2008) (3)
Overview of the clinical genetics of ovarian cancer (2002) (3)
Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome (2012) (3)
Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes , and . (2018) (3)
ATTITUDES TO PREDICTIVE TESTING FOR BRCA1 (1995) (3)
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer (2016) (3)
Psychosocial and Ethical Issues Relating to Genetic Testing for BRCA1 and BRCA2 Breast Cancer Susceptibility Genes (2006) (3)
Sexual development of patients with isochromosomes for the long arm of the X chromosome (2004) (2)
A complex endocrine conundrum (2013) (2)
Molecular and clinico-pathological features of two families with the HNPCC syndrome and unusual phenotypes (1997) (2)
DXS26 (HU16) is located in Xq21.1 (1990) (2)
Prenatal diagnosis of a double bisatellited marker with an unusual copy number ratio (1990) (2)
Our evolving understanding of 22q.11 deletion syndrome. (2005) (2)
Loss of expression of ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN (2012) (2)
A Practical Guide to Human Cancer Genetics: Genetic counselling in a familial cancer clinic (2006) (2)
Genetic testing in other GI diseases. (2009) (2)
650 HEPATITIS B VIRUS DNA LEVELS AND ALT PREDICT SEVERITY OF LIVER INJURY IN CHRONIC HBEAG NEGATIVE DISEASE (2008) (2)
Clinical service development for familial breast cancer in European Countries; the role and training of genetic councellors in this service, and educational provision in cancer genetics (2000) (2)
Nathaniel Comfort: The science of human perfection, how genes became the heart of American Medicine (2013) (1)
syndrome (hereditary non-polyposis cancer) Guidelines for the clinical management of Lynch (2007) (1)
Screening and management of familial colon cancer (2004) (1)
Breast cancer and BRCA1 mutations. (1996) (1)
Familial Breast and Ovarian Cancer: Cultural and educational aspects influencing the development of cancer genetics services in different European countries (2002) (1)
TNF, IFNG and FOXP3 expression in colorectal cancer: potential targets for immunotherapy (2011) (1)
Genetic testing is important in families with a history suggestive of hereditary non‐polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled (1997) (1)
Current breast screening services available throughout Europe to families at increased genetic risk for breast cancer (2000) (1)
The consequences of nuclear war (1980) (1)
phylogenetic approach identified mitochondrial haplogroup T 1 a 1 as inversely associated with breast cancer risk in BRCA 2 mutation carriers (2015) (1)
Screening for breast cancer. Consider family history also. (1994) (1)
Possibility of a dominant negative effect of some point mutations. (2000) (1)
Conference on gene therapy, Royal College of Physicians, London, 1 March 1990. (1990) (1)
W.A. Schultz: Molecular biology of human cancers. An advanced student’s textbook (2008) (1)
Comprar Inherited Susceptibility to Cancer | William D. Foulkes | 9780521104746 | Cambridge University Press (2009) (1)
The Inaugural Birt-Hogg-Dubé (BHD) Symposium (2008) (1)
Comprar A Practical Guide To Human Cancer Genetics | Hodgson, S. | 9781447123743 | Springer (2014) (1)
Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients (2020) (1)
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in $\small \textit{BRCA1}$ and $\small \textit{BRCA2}$ Mutation Carriers (2016) (1)
A novel association of Cowden syndrome and combined hamartoma of retina and retinal pigment epithelium (2010) (1)
A survey of the clinical facilities for the management of familial cancer in Europe: details of the current status (2000) (1)
Familial adenomatous polyposis and genomic imprinting (1992) (1)
Penrose, Lionel Sharples (2006) (1)
Elongin C (ELOC/TCEB1)-associated von Hippel–Lindau disease (2022) (1)
Title Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA 1 and BRCA 2 mutation carriers (2015) (1)
Identification of nine new susceptibility loci for endometrial cancer (2018) (1)
Familial risk of early and late onset cancer. (2013) (1)
Fine-mapping of the HNF1Bmulticancer locus identifies candidate variants thatmediate endometrial cancer risk (2015) (1)
Advances in cancer genetics. (2009) (1)
Breast Cancer Risk and 6 q 22 . 33 : Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA 1 / 2 (2012) (1)
Utilisation of Prophylactic Mastectomy in 10 (1999) (1)
Management of familial adenomatous polyposis. (1992) (1)
Pericentric inversion of chromosome I in an azoospermic man (1)
Cardiorespiratory System and Thorax (2014) (0)
SHORT REPORT Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility (2007) (0)
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (0)
The origin of colorectal neoplasms: Clues to the origin of human cancer (1997) (0)
A Practical Guide to Human Cancer Genetics: Eye (2006) (0)
Screening Those at High Risk for Colorectal Cancer (2004) (0)
prevalence of Fanconi anemia in Gypsy families from Spain A common founder mutation in FANCA underlies the world's highest (2013) (0)
Clinical features of non-syndromic familial phaeochromocytoma (2000) (0)
Radiosensitivity in breast cancer susceptibility. (2005) (0)
Motivation to attend familial cancer genetics centres for advice about a family history of cancer: The PACT psychosocial study. (2003) (0)
FAP and Marfanoid habitus (2000) (0)
Ovarian and breast cancer as part of hereditary non-polyposis colorectal cancer (HNPCC) and other hereditary colorectal cancer syndromes (2002) (0)
Our evolving understanding of 22q.11 deletion syndrome (2005) (0)
Eight cases of 7 p deletion : clinical features , cytogenetic findings , and molecular studies (2013) (0)
The British Familial Cancer Record (BFCR): A model for clinical research into familial cancer. (2003) (0)
Metabolic Fatty Liver Disease (2009) (0)
Studies on the immunohistochemical demonstration of P53 protein in inherited breast cancers correlated with evidence of mutation in the P53 gene (1992) (0)
Best Practice & Research Clinical Obstetrics and Gynaecology (2010) (0)
Risk of subsequent cancers after a diagnosis of female breast cancer (2000) (0)
A Practical Guide to Human Cancer Genetics: Urinary system (2006) (0)
Familial Breast and Ovarian Cancer: Introduction (2002) (0)
Hereditary Cancer (1997) (0)
Clinical investigation of the UK cohort of FLCN mutation positive Birt-Hogg-Dube syndrome patients (2010) (0)
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
Emerging concerns abour Iran's scientific and medical future. (2007) (0)
A Practical Guide to Human Cancer Genetics: Contents (2006) (0)
Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcaemia type 3 (ADH3) (2014) (0)
Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome (2012) (0)
D N A deletions in mild and severe Becker muscular dystrophy (0)
Reply (1995) (0)
A Practical Guide to Human Cancer Genetics: Blood and lymph (2006) (0)
Ageing & cancer susceptibility: Is systemic failure of apoptosis a factor? (2002) (0)
Familial Breast and Ovarian Cancer: Future directions (2002) (0)
Determination of the clonality of colorectal tumours; Clues to the origin of human cancer (1997) (0)
No association between the GSTM1, GSTT1, and GSTP1 gene polymorphisms, squamous cell cancer of the head and neck and second primary tumours (2000) (0)
A guide to the art of taking pedigrees: an analytical and sensitive approach (2000) (0)
A Practical Guide to Human Cancer Genetics: Central nervous system (2006) (0)
60P Real-world experience of immunotherapy in elderly cancer patients in a UK cancer centre (2020) (0)
Chromosome radiosensitivity and apoptosis in breast cancer susceptibility. (2005) (0)
Dominant transmission ofSprengel's shoulder andcleft palate (1981) (0)
Histology, oestrogen and progesterone receptor status in breast tumours from BRCA1 mutation carriers. (2002) (0)
A Practical Guide to Human Cancer Genetics: Skin (2006) (0)
P386: Screening for endometrial cancer in a high‐risk population (Hereditary Non Polyposis Colorectal Cancer)—a pilot study (2003) (0)
Genetic Counselling for Common Diseases, Cancer Susceptibility as Paradigm (2010) (0)
A Practical Guide to Human Cancer Genetics: Reproductive system (2006) (0)
The health of refugees – public health perspectives from crisis to settlement (2020) (0)
Mutation-Specific Survival of Inherited Breast Cancer (2002) (0)
A Practical Guide to Human Cancer Genetics: Cardiorespiratory system and thorax (2006) (0)
The Lancet, Gaza and academic publishing: defending political engagement (2015) (0)
Intratumor Heterogeneity and Evolution of Colorectal Cancer (2020) (0)
ATM in a breast cancer series (2001) (0)
A Practical Guide to Human Cancer Genetics: Gastrointestinal system (2006) (0)
Hunting for the underlying cause of Cushing's syndrome (2012) (0)
Tuberous Sclerosis Complex: From Basic Science to Clinical Phenotypes. International Review of Child Neurology Series, Edited by Paolo Curatolo, London, Mac Keith Press, 2003, pp 328, £55.00, US$75.00, ISBN 1 898683 39 5 (Hardback) (2004) (0)
Genetic Counselling for Cancer Susceptibility (2017) (0)
Pendreds syndrome with three mutations (2006) (0)
A Practical Guide to Human Cancer Genetics: Inherited cancer-predisposing syndromes (2006) (0)
A heartfelt "thank you" to all the reviewers of the Journal of Community Genetics in 2010 (2011) (0)
q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers (2012) (0)
Discovery of 4 possible supernovae during the "Deeper, Wider, Faster" program observations (2017) (0)
A complex endocrine conundrum (2012) (0)
The long term impact of resistant starch on cancer risk in carriers of hereditary colorectal cancer:the CAPP2 Randomised Controlled Trial (2012) (0)
Whole‐genome methylation analysis of benign and malignant colorectal tumours. J Pathol 2013; 229: 697–704 (2013) (0)
Inherited Cancer-Predisposing Syndomes (2014) (0)
Peutz-Jeghers syndrome deletions are not a rare cause of STK11 Exonic (2006) (0)
A Practical Guide to Human Cancer Genetics: Musculoskeletal system (2006) (0)
A Practical Guide to Human Cancer Genetics: References (2006) (0)
Variables associated withtherisk ofcolorectal adenomas inasymptomatic patients with afamily history ofcolorectal cancer (1995) (0)
Becker muscular dystrophy . in families with Duchenne or analysis to genetic counselling The application of linkage (0)
University of Groningen DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Osorio, (2014) (0)
Juvenile polyposis lesions show clonal loss of SMAD4 in epithelial as well as stromal compartments, endorsing the "gatekeeper" not the "landscaper" hypothesis [Abstract] (2000) (0)
Ascertainment and management of patients at increased genetic risk of cancer (2008) (0)
Attitudes topredictive DNA testing infamilial adenomatous polyposis (1996) (0)
Pathology of the breast and ovary in mutation carriers (2002) (0)
War doctor (2019) (0)
Microdeletions, Rearrangements, and Cancer Susceptibility (2016) (0)
HLA is unlikely to be a major component of risk in familial inflammatory bowl disease (1994) (0)
Molecular mechanisms in cancer susceptibility—lessons from inherited cancers (2020) (0)
Analysis of Fanconi Anemia gene inactivation in sporadic squamous cell carcinoma of the head and neck. (2002) (0)
Familial hyperparathyroidism with a mutation in the HRPT2 gene (2006) (0)
A Practical Guide to Human Cancer Genetics: Endocrine system (2006) (0)
Constraints on communication within families about inherited breast cancer: A descriptive study (2000) (0)
Testosterone secreting clear cell ovarian tumor in a patient with Von Hippel Lindau (VHL) disease (2018) (0)
Cyclooxygenase 2 and Wound Healing in the Stomach (1997) (0)
Are Fanconi Anaemia genes inactivated in sporadic acute myeloid leukemia (2002) (0)
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome (2019) (0)
SNP rs2180341 per-allele hazard ratios (HRs) and 95% confidence intervals (CIs) among Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) in A. BRCA1 mutation carriers B. BRCA2 mutation carriers. (2012) (0)
familial adenomatous polyposis . APC mutation associated with late onset of (0)
Field trials of health interventions, 3rd edition: a Toolbox (2015) (0)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (0)
Correlation ofclinical anddeletion datain Duchenne andBecker muscular dystrophy (1989) (0)
Clinical features and molecular analysis of a family with multiple colon tumours and reduced plasminogen activator activity (1997) (0)
Familial Breast and Ovarian Cancer: Management (2002) (0)
Management ofBRCA1/2mutation carriers (2002) (0)
The DCC gene and colorectal cancer: the story is more complex (2008) (0)
Foreword by Helena Kennedy (2002) (0)
Safe haven – the wartime letters of Ben Barman and Margaret Penrose, 1940–1943 (2019) (0)
Geneticists / Genetic Counsellors for Medico-Legal Work (2014) (0)
HNPCC - Where does the buck stop? (2004) (0)
The evaluation of genetic testing in individuals at high risk of colon cancer compared to individuals at high risk of breast cancer. (2000) (0)
Clinical investigation of the UK cohort of FLCN mutation-positive patients with Birt-Hogg-Dube syndrome (2011) (0)
Multiple primary cancers in south-east England: relevance to colon cancer genetic susceptibility. (2000) (0)
Retiring president of M.S.R.C. 1973/74. (1974) (0)
Failure to satisfy the Amsterdam criteria for diagnosis of HPNCC should not preclude 'at risk' families from predictive genetic testing (1998) (0)
myelogenous leukemia Acquired FANCA dysfunction and cytogenetic instability in adult acute (2013) (0)
The inherited aspects and implications for management of paragangliomas. (2002) (0)
University of Groningen Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Couch, (2013) (0)

This paper list is powered by the following services:

Other Resources About Shirley Hodgson

en.wikipedia.org

What Schools Are Affiliated With Shirley Hodgson?

Shirley Hodgson is affiliated with the following schools: